Research!America Pushes Cures, As Advocacy Groups Urge Delay Unless Drug-Pricing Attached

October 28, 2016 at 6:04 PM
Research!America, a public health research alliance whose members include AdvaMed, Johnson & Johnson and Amgen, called for passage of the 21 st Century Cures Act before the end of the 114 th Congress, days after a coalition of groups including labor unions and patient advocates said Congress should not act on Cures unless drug pricing reforms are attached. The brand pharmaceutical lobby declined to lay out its Cures lobbying strategy but told Inside Health Policy it “opposes harmful proposals...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.